Sofosbuvir/Ledipasvir without Ribavirin is effective in the treatment of recurrent hepatitis C infection post liver transplant

被引：0
|
作者：
Shoreibah, Mohamed G. [1 ]
Jones, Deann [1 ]
Orr, Jordan [2 ]
Zhang, Jie [3 ]
Venkata, Krishna V. [4 ]
Massoud, Omar I. [1 ]
机构：
[1] Univ Alabama Birmingham, GI & Hepatol, Birmingham, AL USA
[2] Univ Alabama Birmingham, Internal Med, Birmingham, AL USA
[3] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA
[4] Univ Alabama Montgomery, Internal Med, Montgomery, AL USA
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2003
引用
收藏
页码：995A / 996A
页数：2
相关论文
共 50 条
  • [21] Interferon alfa and ribavirin in established post liver transplant recurrent hepatitis C infection
    Kapur, A
    Rodriguez, MJ
    Schecter, S
    Tzakis, AG
    Schiff, ER
    [J]. GASTROENTEROLOGY, 1998, 114 (04) : A1268 - A1268
  • [22] The efficacy of Sofosbuvir/Ledipasvir or sofosbuvir/daclatasvir based therapies (with/without ribavirin) for recurrent hepatitis C (genotype 1,2) in liver transplantation recipients
    Hu, T. -H
    Chen, C. -L
    Lin, C. -C
    Lin, Y. -H
    [J]. TRANSPLANTATION, 2018, 102 : 113 - 113
  • [23] Sofosbuvir and simeprevir is effective for recurrent hepatitis C in liver transplant recipients
    Saab, Sammy
    Greenberg, Adam
    Li, Edwin
    Bau, Sherona Ngashea
    Durazo, Francisco
    El-Kabany, Mohammed
    Han, Steven
    Busuttil, Ronald W.
    [J]. LIVER INTERNATIONAL, 2015, 35 (11) : 2442 - 2447
  • [24] Outcomes of Ribavirin Free Treatment of Recurrent Genotype 1, Hepatitis C Infection Post Liver Transplant.
    Jones, D.
    Baggett, S.
    Shoreibah, M.
    Massoud, O.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 790 - 790
  • [25] Treatment of Patients with Hepatitis C Virus infection (Genotype 4) with Ledipasvir-Sofosbuvir in the liver transplant setting
    Abaalkhail, Faisal A.
    Elsiesy, Hussein A.
    Al Sebayel, Mohammed
    Aljedai, Ahmed
    Ajlan, Aziza A.
    Elbeshbeshy, Hany
    Al-Hamoudi, Waleed K.
    [J]. HEPATOLOGY, 2016, 64 : 956A - 957A
  • [26] Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
    Demirturk, Nese
    Aygen, Bilgehan
    Celik, Ilhami
    Mistik, Resit
    Akhan, Sila
    Barut, Sener
    Ural, Onur
    Batirel, Ayse
    Simsek, Funda
    Ersoz, Gulden
    Inan, Dilara
    Kinikli, Sami
    Turker, Nesrin
    Bilgin, Huseyin
    Gurbuz, Yunus
    Tulek, Necla
    Tarakci, Huseyin
    Yildiz, Orhan
    Turkoglu, Emine
    Guzel, Deniz Kamalak
    Simsek, Sumeyra
    Tuna, Nazan
    Demir, Nazlim Aktug
    Cagatay, Atahan
    Cetinkaya, Riza Aytac
    Karakecili, Faruk
    Hakyemez, Ismail Necati
    Ertem, Gunay Tuncer
    Ormen, Bahar
    Korkmaz, Pinar
    Sili, Uluhan
    Kuruuzum, Ziya
    Sener, Alper
    Ozel, Selcan Arslan
    Ozturk, Sinan
    Suer, Kaya
    Celen, Mustafa Kemal
    Konya, Petek
    Asan, Ali
    Saltoglu, Nese
    Dogan, Nurhan
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (02): : 155 - 163
  • [27] Ledipasvir/sofosbuvir and ribavirin for the treatment of ribavirin-refractory persistent hepatitis E virus infection
    Gallacher, Jennifer
    Taha, Yusri
    Filipe, Ana da Silva
    Ijaz, Samreen
    McPherson, Stuart
    [J]. IDCASES, 2023, 32
  • [28] Pegylated interferon therapy with/without ribavirin in liver transplant recipients with recurrent hepatitis C infection
    Levitsky, J
    Cohen, SM
    Dasgupta, KA
    Faust, TW
    Te, HS
    [J]. HEPATOLOGY, 2002, 36 (04) : 182A - 182A
  • [29] Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience
    Yoshihide Ueda
    Toru Ikegami
    Nobuhisa Akamatsu
    Akihiko Soyama
    Masahiro Shinoda
    Ryoichi Goto
    Hideaki Okajima
    Tomoharu Yoshizumi
    Akinobu Taketomi
    Yuko Kitagawa
    Susumu Eguchi
    Norihiro Kokudo
    Shinji Uemoto
    Yoshihiko Maehara
    [J]. Journal of Gastroenterology, 2017, 52 : 986 - 991
  • [30] Ribavirin levels in post liver transplant patients treated for recurrent hepatitis C viral infection
    Jain, A
    Vekatramanan, R
    Yelochan, B
    Kashyap, R
    Marcos, A
    Fung, J
    [J]. TRANSPLANTATION PROCEEDINGS, 2005, 37 (07) : 3190 - 3196
12345